Best OGLIOSS 1/0.2 Tablet for Effective Diabetes Control | Glimepiride Metformin Voglibose Tablet

OGLIOSS 1/0.2 Tablet – Glimepiride Metformin Voglibose Tablet for Type 2 Diabetes

OGLIOSS 1/0.2 Tablet is a clinically proven anti-diabetic combination medicine formulated with Glimepiride 1mg, Metformin Hydrochloride 500mg (SR), and Voglibose 0.2mg. This powerful triple-action therapy is designed for the effective management of Type 2 Diabetes Mellitus, especially in patients who are not adequately controlled with single-drug treatment. This Glimepiride Metformin Voglibose Tablet is highly effective in managing Type 2 diabetes. Doctors often prescribe this Glimepiride Metformin Voglibose Tablet for better sugar control.

This advanced bilayer Glimepiride Metformin Voglibose Tablet helps regulate blood sugar levels throughout the day and significantly reduces post-meal glucose spikes, making it an ideal choice for comprehensive diabetes care.

---

 Composition of OGLIOSS 1/0.2 Tablet

Each bilayer tablet contains:

• Glimepiride 1 mg

• Metformin Hydrochloride 500 mg (Sustained Release)

• Voglibose 0.2 mg

This combination provides a synergistic effect to control blood glucose levels effectively.

---

 Mechanism of Action

OGLIOSS 1/0.2 works through a triple-action mechanism, targeting different pathways of glucose control:

1. Glimepiride

Stimulates the pancreas to release insulin, helping lower blood sugar levels.

2. Metformin (SR)

• Reduces glucose production in the liver

• Improves insulin sensitivity

• Enhances peripheral glucose uptake

3. Voglibose

• Delays carbohydrate digestion and absorption in the intestine

• Controls postprandial (after-meal) blood sugar spikes

---

 Key Benefits of Glimepiride Metformin Voglibose Tablet

• Effective control of both fasting and post-meal blood sugar levels

• Provides sustained glucose control throughout the day

• Reduces insulin resistance

• Helps prevent long-term diabetes complications

• Improves overall glycemic management

• Ideal for combination therapy in uncontrolled diabetes patients

---

 Indications

OGLIOSS 1/0.2 Tablet is indicated for:

• Type 2 Diabetes Mellitus

• Patients not responding adequately to monotherapy

• Management of high postprandial blood glucose

• Long-term diabetes control under medical supervision

---

PACKING: 10 x 15 (Blister)

---

 Dosage & Administration

• Take OGLIOSS 1/0.2 Tablet as prescribed by your physician

• Usually taken before meals for better effectiveness

• Swallow whole with water; do not crush or chew

• Maintain a consistent schedule for best results

---

 Precautions & Warnings

• Not suitable for Type 1 Diabetes Mellitus

• Use cautiously in patients with kidney or liver disorders

• Regular monitoring of blood glucose is essential

• Avoid alcohol consumption while taking this medication

• Inform your doctor about any ongoing medications

---

 Possible Side Effects

Like all medicines, this combination may cause some side effects:

• Hypoglycemia (low blood sugar)

• Nausea or stomach upset

• Flatulence or abdominal discomfort

• Diarrhea (rare)

Most side effects are mild and temporary. Consult your doctor if symptoms persist.

---

 Storage Instructions

• Store in a cool and dry place

• Protect from direct sunlight and moisture

• Keep out of reach of children

---

 Frequently Asked Questions (FAQs)

1. What is OGLIOSS 1/0.2 Tablet used for?

It is used to manage Type 2 Diabetes Mellitus and control blood sugar levels effectively.

2. How does this tablet help in diabetes?

It combines three medicines that work together to increase insulin, reduce glucose production, and slow carbohydrate absorption.

3. Can it be taken long-term?

Yes, but only under proper medical supervision and regular monitoring.

4. When should I take this medicine?

It is usually taken before meals as advised by your doctor.

---

 Why Choose OGLIOSS 1/0.2?

OGLIOSS 1/0.2 Tablet offers a comprehensive and scientifically advanced solution for diabetes management with its triple-drug formulation. It ensures better patient compliance, improved blood sugar control, and reduced risk of complications.

Home